HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MHC class I chain-related gene A transmembrane polymorphism in Spanish women with breast cancer.

Abstract
The NKG2D-major histocompatibility complex class I-related chain A (MICA) system plays a key role in the antitumoral immune response. We studied five alleles of a microsatellite in the MICA transmembrane region; one of which (MICA-A5.1) gives rise to a truncated protein. The MICA-A5 allele was reduced in breast cancer patients compared with healthy controls (P = 0.04). Given the association between the HLA-B7 allele and the susceptibility to breast cancer in our area, we also analyzed the distribution of the frequency of the MICA alleles in human leukocyte antigen (HLA)-B7 patients compared with patients with the other alleles. The MICA-A5.1 allele was increased in HLA-B7 patients (P = 0.0003). These results suggest that the MICA-A5 allele appears to confer protection against human breast cancer and that the MICA-A5.1 appears to increase the susceptibility to breast cancer in HLA-B7 patients in our area.
AuthorsR Lavado-Valenzuela, M Benavides, F Carabantes, A Alonso, A Caballero
JournalTissue antigens (Tissue Antigens) Vol. 74 Issue 1 Pg. 46-9 (Jul 2009) ISSN: 1399-0039 [Electronic] England
PMID19392799 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HLA-B7 Antigen
  • Histocompatibility Antigens Class I
  • MHC class I-related chain A
Topics
  • Alleles
  • Breast Neoplasms (epidemiology, genetics)
  • Exons (genetics)
  • Female
  • Gene Frequency (genetics)
  • Genetic Predisposition to Disease
  • HLA-B7 Antigen (genetics)
  • Histocompatibility Antigens Class I (genetics)
  • Humans
  • Microsatellite Repeats (genetics)
  • Polymorphism, Genetic
  • Spain (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: